Jefferies analyst David Steinberg said with yesterday's takeover of Sagent Pharmaceuticals (NASDAQ: SGNT) this was the third company from their ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE